The Global Breast Reconstruction Market size is projected to reach USD 647 million by 2026, at a CAGR of 2.7%. This industry is experiencing significant growth due to rising incidences of breast cancer, increasing awareness, and the availability of reimbursements.
Key Players:
Mentor Worldwide LLC (Johnson Johnson) (US), Allergan Aesthetics (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), and Silimed (Brazil)
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593
Market Dynamics
Drivers
- Increasing incidence of breast cancer
- Growing aging population
- Increasing awareness regarding breast reconstruction treatment
Restraints
- Clinical risks and complications of breast reconstruction procedures
- Alternative non-surgical methods Improving reimbursements for breast reconstruction procedures
Opportunities
- Development of 3D-printed implants
- Rise in preference for biological products
Challenges
- Product failures and recalls
- Dearth of trained professionals
Request Free Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=186501593
North America was the largest regional market for breast reconstruction in 2020
The breast reconstruction market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America held the largest share of the market, followed by Europe. The rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products in this region are the major factors driving the growth of the breast reconstruction in North America.
Recent Developments
- In 2022, Mentor Worldwide LLC (Johnson Johnson) received the US FDA approved a new MENTOR Memory Gel boost breast implant
- In 2021, POLYTECH Health Aesthetics received US FDA approval for the company’s textured breast implants (macrotextured and polyurethane-coated implants)
- In 2020, Sientra received US FDA pre-market approval for its OPUS-branded breast implant products
Report Objectives
- To define, describe, segment, and forecast the breast reconstruction market
- To forecast the size of the market with respect to the main regional segments—North America, Europe, the Asia Pacific, and the Rest of the World
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
- To track and analyze competitive developments such as collaborations, regulatory approvals, partnerships, acquisitions, and product launches in the breast reconstruction market
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=186501593
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: [email protected]
